Donald R. Bullock serves as Executive at Sagent Pharmaceuticals, Inc., where they oversee executive responsibilities. Since joining the company, Donald R. Bullock has executed 3 insider transactions totaling $0, demonstrating a balanced approach to their equity position. Their most recent transaction on Aug 29, 2016 involved selling 8,073 shares valued at $175.6K.
Donald R. Bullock currently holds 8,073 shares of Sagent Pharmaceuticals, Inc. (SGNT), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Donald R. Bullock has been a net neutral trader of SGNT stock. They have purchased $0 and sold $0 worth of shares.
Donald R. Bullock's most recent insider trade was on Aug 29, 2016, when they sold 8,073 shares at $21.75 per share.
Get notified when new Form 4 filings are submitted
| 2,583 |
| $21.75 |
| Discretionary |
| Jun 27, 2016 | SGNT | $0 | Award | 4,993 | $N/A | Discretionary |